Foresite Capital — Full Portfolio
223 tracked investments · page 2 of 2 · listed companies and verified rows first
Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.
Digital HealthHealthtechMedical DevicesSeattle, US
Ben Casavant(Co-Founder and Chief Executive Officer)Erwin Berthier(Co-Founder and Chief Technology Officer)Elizabeth Hambrecht(Director)Alan Levy(Director)Paul Conley(Director)
Third Arc Bio develops breakthrough treatments in oncology and immunology through advanced biologics engineering.
BiotechMedical DevicesLower Gwynedd, US
Joseph Erhardt(Executive Officer)Peter Lebowitz(Executive Officer, Director)
BoardArjun Goyal(Director)Otello Stampacchia(Director)Francesco Draetta(Director)
Thyme Care develops software to enhance care coordination and outcomes for cancer patients.
Digital HealthHealthtechNashville, US
Robert Green(Executive Officer, Director)Robin Shah(Executive Officer, Director)in
BoardBrian Belsky(Director)inElizabeth Canis(Director)inBrenton Fargnoli(Director)inVineeta Agarwala(Director)in
Developing ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral beta-lactam/beta-lactamase inhibitor combination for complicated urinary tract infections.
BiotechLondon
Jan-Anders Karlsson(Executive Officer, Director)David Ebsworth(Director)Patrick Humphrey(Director)Peter Spargo(Executive Officer)Ken Cunningham(Director)Kenneth Newman(Executive Officer)
Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
AI & Machine LearningBiotechMedical Devices
Dr. Ci Chu(Chief Discovery Officer)Dr. Bo Wang(Chief AI Scientist)Dr. Ian McCaffery(SVP, Translational Science and Early Clinical Development)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


